000566 Hainan Haiyao
- 3.08
- -0.07-2.22%
About Hainan Haiyao Company
The company's predecessor, Haikou Pharmaceutical Factory, was founded in 1965 and listed on the Shenzhen Stock Exchange in 1994 (stock code: 000566). It is a leading enterprise in the pharmaceutical industry in Hainan Province. On March 24, 2020, Xinxing Jihua Pharmaceutical and Hainan Haiyao completed a strategic restructuring. Xinhaiyao became a mixed ownership enterprise controlled by a central enterprise, beginning a new journey of Haiyao development. The company focuses on health care, covering the fields of intermediates, APIs, chemical preparations, medical devices, modern traditional Chinese medicine, biomedicine and medical services. Currently, it mainly focuses on R&D, production and sales of pharmaceuticals and medical devices. The company's main products throughout the year include six major series, namely antibiotic series, gastrointestinal medication series, antineoplastic drug series, cochlear implant series, and formulation A set of APIs and intermediates and other products. Company Honors: High-tech Enterprise in Hainan Province; Vice Chairman's Unit; Top 50 Industrial Enterprises in Hainan; Top Ten Tax-Paying Enterprises, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- jianping wang
- Chairman, Directors, Strategy Committee Convener, Nomination Committee Members
- --
- xicheng liu
- Vice Chairman, Directors, Audit Committee Member, Member of the Strategy Committee
- --
- chang liu
- Directors
- --
- duojia feng
- Directors, Member of the Remuneration and Assessment Committee, Audit Committee Member
- --
- junhong wang
- Directors, General Manager, Nomination Committee Members, Member of the Remuneration and Assessment Committee
- 665.10K
- yuexiang zhao
- Directors, Member of the Strategy Committee
- 267.70K
- xiuqun hu
- Independent Directors, Audit Committee Convener, Member of the Remuneration and Assessment Committee, Nomination Committee Members
- 100.00K
- tao lu
- Independent Directors, Audit Committee Members, Remuneration and Assessment Committee Members, Strategy Committee Members, Nomination Committee Convener
- --
- yulin wei
- Independent Directors, Nomination Committee Members, Member of the Strategy Committee, Remuneration and Assessment Committee Convener, Audit Committee Member
- 200.00K
- lei shi
- Board Secretary, Deputy General Manager
- 607.40K
- xiaosu wang
- Securities Affairs Representative
- --
- zengfu zhang
- Chairman of the Supervisory Board, Auditors
- --
- yadong zhou
- Auditors
- --
- hui zhang
- Deputy General Manager
- 515.40K
- rongyi xu
- Head of Finance
- 642.20K
- haifeng yin
- Chief Engineer
- 1.11M
- jianpeng wang
- Sales Director
- 448.40K
Analysis
Price Target
No Data
